Cargando…

EQD2 Analyses of Vaginal Complications in Exclusive Brachytherapy for Postoperative Endometrial Carcinoma

SIMPLE SUMMARY: Vaginal complications in exclusive vaginal-cuff brachytherapy (EVCBT) have not been analyzed in terms of the dose received by a vaginal volume of 2 cm(3). The aim of this work was to analyze the vaginal dose and complications in EVCBT. In the present analysis, we found that all the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yaowen, Fornes, Balbino, Gómez, Gabriela, Bentoldrà, Irene, Carmona, Clara, Herreros, Antonio, Sabater, Sebastià, Nicolás, Inmaculada, Li, Yan, Sánchez, Joan, Biete, Albert, Torné, Aureli, Ascaso, Carlos, Rovirosa, Ángeles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589275/ https://www.ncbi.nlm.nih.gov/pubmed/33092163 http://dx.doi.org/10.3390/cancers12103059

Ejemplares similares

Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: a prospective analysis
por: Zhang, Y., et al.
Publicado: (2021)

Vaginal cuff brachytherapy in endometrial cancer – a technically easy treatment?
por: Sabater, Sebastià, et al.
Publicado: (2017)

Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2‑late vaginal complications in 3D‑vaginal‑cuff brachytherapy (interventional radiotherapy)?
por: Zhang, Yaowen, et al.
Publicado: (2023)

Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction((α/β=3Gy)) at 2 cm(3) of vagina
por: Aguilera, María del Valle, et al.
Publicado: (2018)

Body Mass Index and Doses at Organs at Risk in a Mediterranean Population Treated with Postoperative Vaginal Cuff Brachytherapy
por: Sabater, Sebastia, et al.
Publicado: (2015)

Why is a very easy, useful, old technique underused? An overview of esophageal brachytherapy – interventional radiotherapy
por: Rovirosa, Ángeles, et al.
Publicado: (2022)

In Vivo Verification of Treatment Source Dwell Times in Brachytherapy of Postoperative Endometrial Carcinoma: A Feasibility Study
por: Herreros, Antonio, et al.
Publicado: (2022)

Intraoperative electron radiation therapy after salvage surgery in gynecological cancers and retroperitoneal sarcomas: outcomes and adverse effects
por: Oses, Gabriela, et al.
Publicado: (2022)

Impact of different dose prescription schedules on EQD(2) in high-dose-rate intracavitary brachytherapy of carcinoma cervix
por: Kumar, Mohan, et al.
Publicado: (2019)

Individualized 3D scanning and printing for non-melanoma skin cancer brachytherapy: a financial study for its integration into clinical workflow
por: Arenas, Meritxell, et al.
Publicado: (2017)

High dose interstitial brachytherapy for treatment of carcinoma of the lip as an alternative to surgery: a case report
por: Torres-Quispe, Percy, et al.
Publicado: (2021)

Stages I–III Inoperable Endometrial Carcinoma: A Retrospective Analysis by the Gynaecological Cancer GEC-ESTRO Working Group of Patients Treated with External Beam Irradiation and 3D-Image Guided Brachytherapy †
por: Rovirosa, Ángeles, et al.
Publicado: (2023)

High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation
por: Stiefel, I., et al.
Publicado: (2021)

The usefulness of fleet rectal enemas on high-dose-rate intracavitary cervical cancer brachytherapy. A prospective trial
por: Andres, Ignacio, et al.
Publicado: (2017)

EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates
por: Lancellotta, Valentina, et al.
Publicado: (2022)

Vaginal cuff dehiscence after intracavitary brachytherapy for endometrial cancer
por: Albuquerque, Kevin, et al.
Publicado: (2012)

Voxel based BED and EQD(2) Evaluation of the Radiotherapy Treatment Plan
por: Singh, Gaganpreet, et al.
Publicado: (2018)

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
por: De Sanctis, Vitaliana, et al.
Publicado: (2020)

In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors
por: Sabater, Sebastià, et al.
Publicado: (2021)

Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer
por: Kellas-Ślęczka, Sylwia, et al.
Publicado: (2012)

Oncology: Management of Elderly Cancer Patients
por: Arenas, Meritxell, et al.
Publicado: (2018)

Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal
por: Arenas, Meritxell, et al.
Publicado: (2014)

Equivalent dose in 2 Gy (EQD2) to pelvic lymph nodes using volume based prescription for three brachytherapy applicators — a dosimetric retrospective analysis
por: Revathy, T, et al.
Publicado: (2021)

The effect of central shielding in the dose reporting for cervical cancer in EQD2 era
por: Tharavichitkul, Ekkasit, et al.
Publicado: (2013)

Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy
por: Ozdemir, Yurday, et al.
Publicado: (2017)

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
por: Eldredge-Hindy, Harriet Belding, et al.
Publicado: (2014)

Dosimetric evaluation of vaginal cuff brachytherapy planning in cervical and endometrial cancer patients
por: Sikorska, Katarzyna, et al.
Publicado: (2020)

Preliminary clinical outcomes of patients treated with vaginal brachytherapy alone using multi-channel vaginal brachytherapy applicator in operated early-stage endometrial cancer
por: Rishi, Karthik S., et al.
Publicado: (2021)

The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer
por: Huddleston, Adam, et al.
Publicado: (2015)

Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer
por: Guler, Ozan C., et al.
Publicado: (2014)

Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer
por: Qian, Jack M., et al.
Publicado: (2017)

The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review
por: Lancellotta, Valentina, et al.
Publicado: (2020)

A total EQD(2) greater than 85 Gy for trachea and main bronchus D(2cc) being associated with severe late complications after definitive endobronchial brachytherapy
por: Murakami, Naoya, et al.
Publicado: (2015)

A total EQD(2) greater than 85 Gy for trachea and main bronchus D(2cc) being associated with severe late complications after definitive endobronchial brachytherapy
por: Murakami, Naoya, et al.
Publicado: (2016)

Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients – in view of the recent evidence
por: Serkies, Krystyna, et al.
Publicado: (2021)

Adjuvant vaginal cuff brachytherapy: dosimetric comparison of conventional versus 3-dimensional planning in endometrial cancer
por: Gultekin, Melis, et al.
Publicado: (2020)

Vaginal cuff brachytherapy practice in endometrial cancer patients: a report from the Turkish Oncology Group
por: Bolukbasi, Yasemin, et al.
Publicado: (2021)

Dosimetric impact of cylinder size in high‐dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer
por: Zhang, Hualin, et al.
Publicado: (2016)

Regression models for predicting physical and EQD(2) plan parameters of two methods of hybrid planning for stage III NSCLC
por: Wang, Hao, et al.
Publicado: (2021)

New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer
por: Holub, Katarzyna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bhuhvceu50r2jivub6jk6rse0d